Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4ATAC11P (RNA, U4atac small nuclear 11, pseudogene) is a non-protein-coding genomic locus homologous to the functional snRNA gene *RNU4ATAC*, which encodes the U4atac small nuclear RNA—an essential component of the minor spliceosome involved in the splicing of U12-type introns[2][1]. The RNU4ATAC11P pseudogene does not produce functional RNA or protein; instead, it represents a duplicated or mutated sequence that has lost its original function. While functional *RNU4ATAC* variants are associated with rare developmental disorders due to their critical role in mRNA splicing, RNU4ATAC11P itself has no established biological activity, disease association, or drug interactions and is not considered a valid therapeutic target[1][2]. If you require information about the **functional RNU4ATAC gene** or the minor spliceosome, those are distinct entities with well-characterized biological and clinical relevance[5].
No mechanisms of action are identified, as there are no drugs or agents known to interact with RNU4ATAC11P
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 11, pseudogene (RNU4ATAC11P).